Tag: biopharma
Merck announces 2025 Merck Young Scientist Award
Sixteen winners will be announced in November 2025
India’s pharma exports surge to US$ 4.96 Bn in April–May FY26:...
Enhance strategies to drive sustainability, global reach and digital transformation for a trillion-dollar future
“Biomanufacturing has shifted focus from just being efficient to staying ahead...
Sachin Joshi, Managing Director & Founder, PharmNXT Biotech shares insights on the company’s focus on innovation, key product offerings, upcoming initiatives, sustainability and future plans
Bharat Biotech–GSK partnership slashes price of world’s first malaria vaccine for...
Price reduction driven by process improvements, expanded production capacity, cost-effective manufacturing, and minimal profit margins
Utopia Therapeutics secures $1.5M investment from Whale Tank to advance preclinical...
The funding will support preclinical development of UT009, Utopia’s lead immunotherapeutic candidate targeting obesity
Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction & a safety...
Lilly plans to submit efsitora for the treatment of adults with type 2 diabetes to global regulatory agencies by the end of this year
OneSource and Xbrane Biopharma enter into strategic biosimilars manufacturing partnership for...
The lead candidate Ximluci (a ranibizumab biosimilar) is granted market authorization approval in Europe (launched in 2023) and is now under the approval process for the US launch
Bürkert Fluid Control Systems invests in Green Elephant Biotech to drive...
This partnership should enable more cost-effective production of therapeutics and facilitate access to the latest biopharmaceutical trends.
UK biopharma venture financing QoQ doubles to $1.1 billion in Q1...
This surge highlights investor appetite for breakthrough innovation, but growing dependence on US capital and policy-driven cost pressures signal an urgent need to strengthen domestic investment
Biocon gets six-month extension on insulin supply pact in Malaysia
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025